Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression

Ashrafizadeh, Milad; Mirzaei, Sepideh; Gholami, Mohammad; Hashemi, Farid; Zabolian, Amirhossein; Raei, Mehdi; Hushmandi, Kiavash; Zarrabi, Ali; H. Voelcker, Nicolas; Reza Aref, Amir; R. Hamblin, Michael; S. Varma, Rajender; Samarghandian, Saeed; Arostegi, I.J.; Alzola, M.; Prem Kumar, Alan; Kumar Thakur, Vijay; Nabavi, Noushin; Makvandi, Pooyan; R. Tay, Franklin; Orive, Gorka

doi:10.1016/j.carbpol.2021.118491

Public

Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression

Published in Carbohydrate Polymers • Jul 27, 2021

Authors:

Milad Ashrafizadeh

Sepideh Mirzaei

Mohammad Gholami

Abstract

An important motivation for the use of nanomaterials and nanoarchitectures in cancer therapy emanates from the widespread emergence of drug resistance. Although doxorubicin (DOX) induces cell cycle arrest and DNA damage by suppressing topoisomerase activity, resistance to DOX has severely restricted...

Subject

Nanocarriers

Hyaluronic acid

Doxorubicin

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!